30 percent of patients are excluded from insurance coverage of COX-2 inhibitor

One out of three patients treated with COX (cyclooxygenase)-2 inhibitor, an anti-arthritic agent, does not give access to the insurance coverage, a survey said recently.

The nationwide survey of 111 doctors in the departments of orthopedic surgery and rheumatoid internal medicine, which were conduced by AC Nielsen on the effects of the government's drug-related policy to discourage the use o...